医療機器償還市場：保険業者別、医療環境別、予測、2023年～2032年

世界の医療機器償還の市場規模は、いくつかの経済圏における好ましい規制環境により、2023年から2032年にかけて7.3%のCAGRで拡大すると予想されます。

規制状況は医療機器償還に大きな影響を与えます。米国のFDAや欧州の欧州医薬品庁（EMA）などの政府機関は、医療機器の承認と償還の経路を確立しています。

承認プロセス、表示義務、市販後調査などの規制の変更は、機器メーカーの償還戦略に直接影響を与え、市場の成長と発展につながります。例えば、フランスでは2023年7月に、遠隔患者モニタリングやデジタル治療用のデジタル機器が迅速なアクセスと償還の対象となり、このプロセスはドイツのDiGAプログラムと類似している、とフランス保健省のLouisa Stuweは述べています。

医療機器償還市場全体は、保険業者、医療環境、地域によって区分されます。

民間保険業者は、より柔軟でカスタマイズされた保険適用オプションを提供できるため、2023年から2032年にかけてCAGR 7%を記録し、2032年までに医療機器償還市場シェアを独占する可能性があります。厳しい規制や限られた予算で運営されることが多い政府系プログラムとは異なり、民間保険業者は新しい技術や治療法に迅速に対応することができます。この適応性の高さが、包括的な補償を求める患者と、より迅速な償還プロセスを求める医療機器メーカーの双方を惹きつけ、医療機器償還制度における民間保険機関の参入急増を後押ししています。

医療機器償還業界の外来患者施設セグメントは、2032年までCAGR 7.9%で拡大する可能性があります。高度で低侵襲な手技を外来で提供する傾向が強まっており、償還可能な医療機器のニーズが高まっています。さらに、外来施設は病院よりも費用対効果が高いため、患者と保険業者の双方にとって魅力的な選択肢となっています。その結果、外来診療に対する需要の高まりが、こうした進化する医療提供モデルをサポートする医療機器償還ソリューションの必要性を高めています。

欧州の医療機器償還産業は、2023年から2032年にかけて7%の成長率を示します。医療支出の増加、高齢化、慢性疾患の蔓延が、革新的な医療技術への需要を促進しています。また、欧州政府は最先端の医療機器へのアクセスを容易にするため、償還政策を改革しています。さらに、デジタルヘルスソリューションの成長と価値に基づくケアモデルの重視が、欧州全域での医療機器償還分野の拡大に寄与しています。

目次

第1章 調査手法

• 産業カバレッジ
• 市場範囲と定義
• 基本推定と作業
  • データ収集
• 予測パラメータ
• 世界レベルでのCOVID-19の影響
• データの検証
• データソース
  • 一次
  • 二次
    • 有料ソース
    • 無料ソース

第2章 エグゼクティブサマリー

第3章 医療機器償還業界の考察

• エコシステム分析
• 業界への影響要因
  • 促進要因
    • 様々な慢性疾患の増加
    • 高齢化人口の増加
    • 医療コスト負担の増大
    • 政府による支援プログラム
  • 業界の潜在的リスク＆課題
    • 複雑な枠組み
    • 限られた保険適用範囲と償還施設
• 成長可能性分析
  • 保険業者別
  • 医療環境別
• COVID-19影響分析
• 規制状況
• 技術情勢
• 今後の市場動向
• 政策イニシアティブ
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
• 企業マトリックス分析
• 競合ポジショニングマトリックス
• ベンダーマトリックス分析
• 企業シェア分析
• 戦略ダッシュボード

第5章 医療機器償還の市場規模・予測：保険業者別

• 主要動向
• 公的
• 民間

第6章 医療機器償還の市場規模・予測：医療環境別

• 主要動向
• 病院
• 外来患者施設
• その他

第7章 医療機器償還の市場規模・予測：地域別

• 主要動向
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • ポーランド
  • スウェーデン
  • オランダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • インドネシア
  • フィリピン
  • ベトナム
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • コロンビア
  • チリ
  • ペルー
• MEA
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • トルコ
  • イスラエル
  • イラン

第8章 企業プロファイル

• CVS Health
• BNP Paribas
• Aviva
• Cigna
• United Health Group
• Allianz
• Aetna
• Humana Inc.
• WellCare Health Plans, Inc.
• Nippon Life Insurance Company
• Anthem Insurance Companies, Inc.

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by payer (2022)
• TABLE 3 Market revenue, by healthcare setting (2022)
• TABLE 4 Market revenue, by region (2022)
• TABLE 5 Global medical devices reimbursement market, 2018 - 2024 (USD Billion)
• TABLE 6 Global medical devices reimbursement market, 2025 - 2032 (USD Billion)
• TABLE 7 Global medical devices reimbursement market, by region, 2018 - 2024 (USD Billion)
• TABLE 8 Global medical devices reimbursement market, by region, 2025 - 2032 (USD Billion)
• TABLE 9 Global medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 10 Global medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 11 Global medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 12 Global medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 13 Industry impact forces
• TABLE 14 Public market estimates and forecast, 2018-2024 (USD Billion)
• TABLE 15 Public market estimates and forecast, 2025-2032 (USD Billion)
• TABLE 16 Private market estimates and forecast, 2018-2024 (USD Billion)
• TABLE 17 Private market estimates and forecast, 2025-2032 (USD Billion)
• TABLE 18 Hospitals market estimates and forecast, 2018-2024 (USD Billion)
• TABLE 19 Hospitals market estimates and forecast, 2025-2032 (USD Billion)
• TABLE 20 Outpatient facilities market estimates and forecast, 2018-2024 (USD Billion)
• TABLE 21 Outpatient facilities market estimates and forecast, 2025-2032 (USD Billion)
• TABLE 22 Others market estimates and forecast, 2018-2024 (USD Billion)
• TABLE 23 Others market estimates and forecast, 2025-2032 (USD Billion)
• TABLE 24 North America medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
• TABLE 25 North America medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
• TABLE 26 North America medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 27 North America medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 28 North America medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 29 North America medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 30 U.S. medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 31 U.S. medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 32 U.S. medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 33 U.S. medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 34 Canada medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 35 Canada medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 36 Canada medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 37 Canada medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 38 Europe medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
• TABLE 39 Europe medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
• TABLE 40 Europe medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 41 Europe medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 42 Europe medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 43 Europe medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 44 Germany medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 45 Germany medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 46 Germany medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 47 Germany medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 48 UK medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 49 UK medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 50 UK medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 51 UK medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 52 France medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 53 France medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 54 France medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 55 France medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 56 Spain medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 57 Spain medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 58 Spain medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 59 Spain medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 60 Italy medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 61 Italy medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 62 Italy medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 63 Italy medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 64 Poland medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 65 Poland medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 66 Poland medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 67 Poland medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 68 Sweden medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 69 Sweden medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 70 Sweden medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 71 Sweden medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 72 The Netherlands medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 73 The Netherlands medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 74 The Netherlands medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 75 The Netherlands medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 76 Asia Pacific medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
• TABLE 77 Asia Pacific medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
• TABLE 78 Asia Pacific medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 79 Asia Pacific medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 80 Asia Pacific medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 81 Asia Pacific medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 82 China medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 83 China medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 84 China medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 85 China medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 86 Japan medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 87 Japan medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 88 Japan medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 89 Japan medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 90 India medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 91 India medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 92 India medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 93 India medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 94 Australia medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 95 Australia medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 96 Australia medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 97 Australia medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 98 South Korea medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 99 South Korea medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 100 South Korea medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 101 South Korea medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 102 Indonesia medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 103 Indonesia medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 104 Indonesia medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 105 Indonesia medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 106 Philippines medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 107 Philippines medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 108 Philippines medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 109 Philippines medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 110 Vietnam medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 111 Vietnam medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 112 Vietnam medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 113 Vietnam medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 114 Latin America medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
• TABLE 115 Latin America medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
• TABLE 116 Latin America medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 117 Latin America medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 118 Latin America medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 119 Latin America medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 120 Brazil medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 121 Brazil medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 122 Brazil medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 123 Brazil medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 124 Mexico medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 125 Mexico medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 126 Mexico medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 127 Mexico medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 128 Argentina medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 129 Argentina medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 130 Argentina medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 131 Argentina medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 132 Columbia medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 133 Columbia medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 134 Columbia medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 135 Columbia medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 136 Peru medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 137 Peru medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 138 Peru medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 139 Peru medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 140 Chile medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 141 Chile medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 142 Chile medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 143 Chile medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 144 MEA medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
• TABLE 145 MEA medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
• TABLE 146 MEA medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 147 MEA medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 148 MEA medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 149 MEA medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 150 South Africa medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 151 South Africa medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 152 South Africa medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 153 South Africa medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 154 Saudi Arabia medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 155 Saudi Arabia medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 156 Saudi Arabia medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 157 Saudi Arabia medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 158 UAE medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 159 UAE medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 160 UAE medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 161 UAE medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 162 Turkey medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 163 Turkey medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 164 Turkey medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 165 Turkey medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 166 Israel medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 167 Israel medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 168 Israel medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 169 Israel medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
• TABLE 170 Iran medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
• TABLE 171 Iran medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
• TABLE 172 Iran medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
• TABLE 173 Iran medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)

Charts & Figures

• FIG. 1 GMI report coverage: Critical research elements
• FIG. 2 Industry segmentation
• FIG. 3 Top-down approach
• FIG. 4 Market estimation and forecast methodology
• FIG. 5 Breakdown of primary participants
• FIG. 6 Medical devices reimbursement industry 360 degree synopsis, 2018 - 2032
• FIG. 7 Industry landscape, 2018 - 2032 (USD Billion)
• FIG. 8 Growth potential analysis, by payer
• FIG. 9 Growth potential analysis, by healthcare setting
• FIG. 10 Porter's analysis
• FIG. 11 PESTEL analysis
• FIG. 12 Company matrix analysis, 2022
• FIG. 13 Competitive positioning matrix
• FIG. 14 Vendor matrix analysis
• FIG. 15 Company market share analysis, 2022
• FIG. 16 Strategy dashboard, 2022

Global Medical Devices Reimbursement Market size will expand at 7.3% CAGR between 2023 and 2032, driven by the favorable regulatory environment across several economies. The regulatory landscape significantly impacts medical device reimbursement. Government agencies, such as the FDA in the United States and the European Medicines Agency (EMA) in Europe, establish the approval and reimbursement pathways for medical devices.

Changes in regulations, including the approval process, labeling requirements, and post-market surveillance, can directly impact reimbursement strategies for device manufacturers, leading to market growth and development. For instance, in July 2023, digital devices for remote patient monitoring and digital therapeutics in France are now eligible for expedited access and reimbursement, a process that bears similarities to Germany's DiGA program, as stated by Louisa Stuwe from the French Ministry of Health.

The overall medical devices reimbursement market is segregated based on payer, healthcare setting, and region.

Private payers could register a 7% CAGR from 2023 to 2032 and dominate the medical devices reimbursement market share by 2032 due to their ability to offer more flexibility and customized coverage options. Unlike government-funded programs that often have stringent regulations and limited budgets, private payers can adapt quickly to new technologies and therapies. This adaptability attracts both patients seeking comprehensive coverage and device manufacturers looking for faster reimbursement processes, driving the surge in private payer participation within the medical device reimbursement landscape.

The outpatient facilities segment of the medical devices reimbursement industry could expand at 7.9% CAGR through 2032. There is a growing trend toward providing advanced, minimally invasive procedures in outpatient settings, increasing the need for reimbursable medical devices. Additionally, outpatient facilities are more cost-effective than hospitals, making them an attractive option for both patients and payers. As a result, the increasing demand for outpatient care is fueling the need for medical device reimbursement solutions to support these evolving healthcare delivery models.

Europe medical device reimbursement industry will exhibit a 7% growth rate throughout 2023-2032. Rising healthcare expenditures, an aging population, and the increasing prevalence of chronic diseases are driving demand for innovative medical technologies. European governments are also reforming reimbursement policies to facilitate access to cutting-edge medical devices. Furthermore, the growth of digital health solutions and greater emphasis on value-based care models are contributing to the expansion of the medical device reimbursement sector across Europe.

Table of Contents

Chapter 1 Methodology

• 1.1 Industry coverage
• 1.2 Market scope & definitions
• 1.3 Base estimates & working
  • 1.3.1 Data collection
• 1.4 Forecast parameters
• 1.5 COVID-19 impact at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Medical devices reimbursement industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Payer trends
  • 2.1.4 Healthcare setting trends

Chapter 3 Medical Devices Reimbursement Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of various chronic diseases
    • 3.2.1.2 Rising aging population
    • 3.2.1.3 Growing burden of healthcare cost
    • 3.2.1.4 Supportive government programs
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Complex framework
    • 3.2.2.2 Limited coverage and reimbursement facilities
• 3.3 Growth potential analysis
  • 3.3.1 By payer
  • 3.3.2 By healthcare setting
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
  • 3.5.1 North America
  • 3.5.2 Europe
  • 3.5.3 Asia Pacific
  • 3.5.4 Latin America
  • 3.5.5 MEA
• 3.6 Technology landscape
• 3.7 Future market trends
• 3.8 Policy initiatives
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive positioning matrix
• 4.4 Vendor matrix analysis
• 4.5 Company market share analysis, 2022
• 4.6 Strategy dashboard, 2022

Chapter 5 Medical Devices Reimbursement Market Size and Forecast, By Payer (USD Billion)

• 5.1 Key payer trends
• 5.2 Public
• 5.3 Private

Chapter 6 Medical Devices Reimbursement Market Size and Forecast, By Healthcare Setting (USD Billion)

• 6.1 Key healthcare setting trends
• 6.2 Hospitals
• 6.3 Outpatient facilities
• 6.4 Others

Chapter 7 Medical Devices Reimbursement Market Size and Forecast, By Region (USD Billion)

• 7.1 Key regional trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Poland
  • 7.3.7 Sweden
  • 7.3.8 The Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
  • 7.4.6 Indonesia
  • 7.4.7 Philippines
  • 7.4.8 Vietnam
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
  • 7.5.4 Columbia
  • 7.5.5 Chile
  • 7.5.6 Peru
• 7.6 MEA
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE
  • 7.6.4 Turkey
  • 7.6.5 Israel
  • 7.6.6 Iran

Chapter 8 Company Profiles

• 8.1 CVS Health
• 8.2 BNP Paribas
• 8.3 Aviva
• 8.4 Cigna
• 8.5 United Health Group
• 8.6 Allianz
• 8.7 Aetna
• 8.8 Humana Inc.
• 8.9 WellCare Health Plans, Inc.
• 8.10 Nippon Life Insurance Company
• 8.11 Anthem Insurance Companies, Inc.